2025-10-22T16:24:43-05:00 2024-12-31 135565207 KPMG LLP 191 WEST NATIONWIDE BLVD SUITE 500 COLUMBUS OH 432152568 990 2024-01-01 203238867 ALVERNO PROVENA HOSPITAL LABORATORIES INC ALVE 2198034789 2434 INTERSTATE PLAZA DRIVE HAMMOND IN 46324 DALE KAHN INTERIM CO-CEO 2198034789 2025-10-22 1 1 MOLLIE P LONGHOUSE P00294881 6142492300 2025-10-21 2024 2025-03-06 01:10:19Z DALE KAHN 2434 INTERSTATE PLAZA DRIVE HAMMOND IN 46324 202182220 0 X WWW.ALVERNOLABS.COM X 2005 IN BRINGING CHRIST'S MINISTRY TO THOSE WE SERVE THROUGH TIMELY HIGH-QUALITY LABORATORY TESTING TO OUR 14 NOT-FOR-PROFIT HOSPITALS AND AFFILIATES LOCATED THROUGHOUT ILLINOIS AND INDIANA. 7 7 0 7 0 0 0 0 193608074 198498603 482145 582089 0 0 194090219 199080692 0 0 0 0 0 0 0 0 0 194137980 199120369 194137980 199120369 -47761 -39677 25578423 22284584 25428423 22134584 150000 150000 X SEE SCHEDULE O 0 0 181271255 198498603 ALVERNO PROVENA HOSPITAL LABORATORIES, INC.'S (APHL) PRIMARY FUNCTION IS TO PROVIDE LABORATORY TESTING SERVICES TO ITS FOURTEEN (14) AFFILIATED NOT-FOR-PROFIT HOSPITALS AND AFFILIATES LOCATED THROUGHOUT ILLINOIS AND INDIANA. THE ORGANIZATION MAINTAINS A STRATEGIC PLAN THAT IS STRUCTURED ON THE FOLLOWING FIVE AREAS: STEWARDSHIP, PEOPLE, SERVICE, GROWTH, AND QUALITY. (CONTINUED IN SCHEDULE O) 181271255 1 0 0 0 0 0 0 0 0 0 1 1 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 24 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 7 7 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 0 0 IL X STEVE WOJNICKI 2198034789 2434 INTERSTATE PLAZA DRIVE HAMMOND IN 46324 THOMAS GRYZBEK CHAIR 1.00 1.00 X X 0 0 0 DOUG CARTER VICE CHAIR (TERM JAN24) 1.00 1.00 X X 0 0 0 ROBERT SUMTER VICE CHAIR 1.00 1.00 X X 0 0 0 JENNIFER MARION DIRECTOR 1.00 1.00 X 0 0 0 MARK FRITSCH MD DIRECTOR 1.00 1.00 X 0 0 0 DEAN HOBSON DIRECTOR 1.00 1.00 X 0 0 0 DR JAMES CALLAGHAN DIRECTOR 1.00 1.00 X 0 0 0 DR JANIS ATKINSON DIRECTOR 1.00 1.00 X 0 0 0 SAMUEL C TERESE CEO/PRESIDENT 32.00 8.00 X 0 752652 34547 STEVEN G WOJNICKI VP FINANCE 32.00 8.00 X 0 449993 34273 BERNARD H HENRY VP HUMAN RESOURCES 32.00 8.00 X 0 370318 33467 D MICHELE LANGE HR DIRECTOR (START DEC24) 40.00 0.00 X 0 126281 12611 SHIRLEY KOREN REGIONAL LAB DIRECTOR 40.00 0.00 X 0 180523 36551 ROBIN ADES REGIONAL LAB DIRECTOR 40.00 0.00 X 0 176449 20701 ABDELRAHMAN ABDELHADI ASSOCIATE REGIONAL LAB DIRECTOR 40.00 0.00 X 0 161571 35523 JENNIFER BINDER LAB DIRECTOR III 40.00 0.00 X 0 145078 19582 CHAD HANSON LAB DIRECTOR III 40.00 0.00 X 0 141140 31315 0 2504005 258570 0 0 1 0 ALVERNO LABORATORIES LLC 113 EAST 4TH ST MICHIGAN CITY IN 46360 LAB & MANAGEMENT 40310459 ALVERNO CLINICAL LABORATORIES LLC 2434 INTERSTATE PLAZA DRIVE HAMMOND IN 46324 LAB & MANAGEMENT 31978621 HEALTHTRUST WORKFORCE SOLUTIONS LLC PO BOX 742697 ATLANTA GA 30374 PURCHASED SERVICES 1325785 MEDSPEED LLC 140 INDUSTRIAL DRIVE ELMHURST IL 60126 COURIER SERVICES 756996 MEDICAL INSTRUMENTATION CO 1640 ELK BLVD DES PLAINES IL 60016 REFERENCE LAB 133353 9 LAB SERVICES FOR PATRON HOSPITALS 621500 198498603 198498603 198498603 582089 582089 3101528 3101528 0 199080692 198498603 0 582089 X 62269753 59235403 3034350 1061207 1061207 2136991 2136991 74864 74864 558 558 COMPENSATION PAID BY AC 82327406 73224358 9103048 MEDICAL SUPPLIES 31142471 31142471 REFERENCE LABORATORY 11837820 11837820 ALL OTHER EXPENSES 8023489 2311773 5711716 245810 245810 199120369 181271255 17849114 0 0 0 7516349 8258769 0 0 5098315 1529272 0 0 0 0 0 0 0 0 453581 216395 6246 0 0 6246 0 0 11382289 10181555 0 0 0 0 1127889 2092347 25578423 22284584 13501162 10359672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11927261 11774912 25428423 22134584 X 150000 150000 0 0 150000 150000 25578423 22284584 -39677 39677 0 X 0 0 0 X 6246 6246 6246 MONEY MARKET FUND 10181555 F 10181555 RIGHT OF USE ASSETS 2092347 2092347 DUE TO RELATED PARTIES 8531577 RETIREMENT BENEFIT LIABILITY 1150988 CURRENT PORTION OF OPERATING LEASE 760928 LONG-TERM OPERATING LEASE LIABILITY 1331419 11774912 1 0 0 0 0 0 0 0 0 SAMUEL C TERESE CEO/PRESIDENT 0 573802 0 178850 0 0 0 13800 0 20747 0 787199 0 0 STEVEN G WOJNICKI VP FINANCE 0 362677 0 87316 0 0 0 13800 0 20473 0 484266 0 0 BERNARD H HENRY VP HUMAN RESOURCES 0 299375 0 70943 0 0 0 11664 0 21803 0 403785 0 0 SHIRLEY KOREN REGIONAL LAB DIRECTOR 0 180523 0 0 0 0 0 7454 0 29097 0 217074 0 0 ROBIN ADES REGIONAL LAB DIRECTOR 0 176449 0 0 0 0 0 7201 0 13500 0 197150 0 0 ABDELRAHMAN ABDELHADI ASSOCIATE REGIONAL LAB DIRECTOR 0 161571 0 0 0 0 0 6704 0 28819 0 197094 0 0 CHAD HANSON LAB DIRECTOR III 0 141140 0 0 0 0 0 5899 0 25416 0 172455 0 0 JENNIFER BINDER LAB DIRECTOR III 0 59059 0 0 0 86019 0 2107 0 17475 0 164660 0 0 PART I, LINE 3 ALVERNO CLINICAL LABORATORIES, LLC (ACL), A RELATED ORGANIZATION IS THE PAY AGENT FOR ALVERNO PROVENA HOSPITAL LABORATORIES, INC. (APHL). ACL USED THE FOLLOWING METHODS TO ESTABLISH COMPENSATION FOR APHL'S TOP MANAGEMENT OFFICIALS: -INDEPENDENT COMPENSATION CONSULTANT -APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE -COMPENSATION COMMITTEE -COMPENSATION SURVEY OR STUDY PART I, LINE 4A SEVERANCE: JENNIFER BINDER - $71,886 FORM 990, PART III, LINE 1: BRINGING CHRIST'S MINISTRY TO THOSE WE SERVE THROUGH TIMELY HIGH-QUALITY LABORATORY TESTING TO OUR 14 NOT-FOR-PROFIT HOSPITALS AND AFFILIATES LOCATED THROUGHOUT ILLINOIS AND INDIANA. FORM 990, PART III, LINE 4A: PROGRAM SERVICE ACCOMPLISHMENTS: APHL'S LONG TERM OBJECTIVE IS TO CONTINUE TO GROW SO AS TO PROVIDE QUALITY LABORATORY SERVICES TO OUR PATRON FAITH BASED HOSPITALS. IN SO DOING, APHL'S LONG TERM OBJECTIVE IS TO CONTROL COSTS, AND TO INCREASE THE NUMBER OF TESTS AVAILABLE, WITH A FOCUS ON HIGHLY RELIABLE SCIENTIFIC TEST RESULTS WHILE BUILDING A CULTURE OF SERVICE. APHL SEEKS TO ATTRACT A WORK FORCE DEDICATED TO SERVICE OF ITS PATIENTS. APHL'S SHORT TERM OBJECTIVES INCLUDE THE ENHANCEMENT OF THE COST MODEL TO IMPROVE THE RELATIVE VALUE UNIT THAT CAPTURES THE COMPLEXITY AND QUANTITATES THE PRODUCTION COST SO AS TO PROVIDE THE COOPERATIVE WITH AN INTEGRATED DELIVERY SYSTEM TO PROVIDE FOR PATIENT NEEDS ON THE PRODUCTION SIDE. THE USE OF LEAN CONCEPTS PROMOTES THE ELIMINATION OF WASTE AND THE EFFICIENT FLOW OF PRODUCTION. SCORE CARDS ARE IN PLACE AND MONITORED FOR QUALITY INTERVENTION NEED. APPROXIMATELY 16,690 TESTS A DAY ARE PERFORMED AT THE CENTRAL LABORATORY WHILE MAINTAINING RAPID RESPONSE LABORATORIES AT EACH HOSPITAL SITE. EACH LABORATORY SITE IS INSPECTED BY CAP AND PROVIDED A CERTIFICATION IN ADDITION TO THE INTERNAL APHL QUALITY DEPARTMENT INSPECTIONS AND PROGRAMS PROMOTING EXCELLENCE IN LABORATORY SCIENCE. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS TWO CLASSES OF MEMBERS, VOTING AND NON-VOTING. THE ORGANIZATION HAS ONE CLASS OF VOTING MEMBERS, REFERRED TO AS PARTICIPANT HOSPITALS. EACH PARTICIPANT HAS THE RIGHT TO APPOINT BOARD MEMBERS WHO HAVE THE RIGHT TO VOTE ON ALL MATTERS PRESENTED TO THE MEMBERS OF THE CORPORATION, INCLUDING THE ELECTION OF DIRECTORS. THE PATRONS DO NOT HAVE VOTING RIGHTS. CURRENTLY, APHL, INC. HAS THREE PARTICIPANTS AND NO PATRONS. FORM 990, PART VI, SECTION A, LINE 7A PARTICIPANT HOSPITAL SYSTEM REPRESENTATIVES ARE APPOINTED BY THE PARTICIPANT HOSPITAL SYSTEM OF APHL'S PARENT ORGANIZATIONS. THE PARTICIPANT HOSPITAL SYSTEM REPRESENTATIVES CAN ACT ON BEHALF OF THE PARTICIPANT HOSPITAL SYSTEM CEO ON ALL MATTERS. FORM 990, PART VI, SECTION A, LINE 7B THE PARTICIPANT HOSPITAL SYSTEMS SHALL HAVE THE EXCLUSIVE POWER TO: A) APPROVE THE ADMISSION OF ADDITIONAL PARTICIPANTS OF THE CORPORATION. B) APPOINT AND REMOVE DIRECTORS AND FILL VACANCIES ON THE BOARD OF DIRECTORS. C) APPOINT AND REMOVE THE PRESIDENT OF THE CORPORATION. D) APPROVE AMENDMENTS AND/OR RESTATEMENTS FROM TIME TO TIME TO THE ARTICLES PROPOSED BY THE BOARD OF DIRECTORS. E) APPROVE AMENDMENT OR REPEAL OF THE BYLAWS AND THE ADOPTION OF NEW BYLAWS. F) APPROVE THE SALE, LEASE, PURCHASE, EXCHANGE, OR DISPOSITION OF ALL OR SUBSTANTIALLY ALL OF THE PROPERTY AND ASSETS OF THE CORPORATION OR THE DISPOSITION OF ASSETS OF THE CORPORATION OTHER THAN IN THE ORDINARY COURSE OF BUSINESS. G) APPROVE THE VOLUNTARY DISSOLUTION OF THE CORPORATION OR THE MERGER OR CONSOLIDATION OF THE CORPORATION WITH ANOTHER CORPORATION. H) APPROVE THE PLAN FOR ALLOCATION AND DISTRIBUTION OF THE CORPORATION'S PROPERTY UPON DISSOLUTION IF NOT OTHERWISE PROVIDED FOR UNDER THE BYLAWS. I) APPROVE PARTICIPANTS' REQUIRED CAPITAL CONTRIBUTIONS TO THE CORPORATION OR DUES PAYABLE TO THE CORPORATION. J) APPROVE THE INCURRENCE OF DEBT BY THE CORPORATION IN EXCESS OF AMOUNTS DETERMINED FROM TIME TO TIME BY THE PARTICIPANTS. K) ADOPT THE ANNUAL CAPITAL AND OPERATING BUDGETS OF THE COMPANY, AND ANY MATERIAL DEVIATIONS THEREFROM, SUCH ANNUAL BUDGETS TO INCLUDE ANY PREVIOUSLY APPROVED CAPITAL CONTRIBUTIONS. L) ADOPT THE STRATEGIC PLANS FOR THE CORPORATION AND APPROVE ANY MATERIAL CHANGES TO THE SERVICES OFFERED BY THE CORPORATION WHICH ARE NOT EXPRESSLY IDENTIFIED IN THE PREVIOUSLY APPROVED STRATEGIC PLANS. M) ORGANIZE OR ACQUIRE, OR AUTHORIZE THE ORGANIZATION OR ACQUISITION OF, ANY SUBSIDIARY OR AFFILIATE OF THE CORPORATION; AND N) APPROVE ANY AMENDMENTS TO THE COOPERATIVE SERVICES AGREEMENT AMONG THE CORPORATION AND THE PARTICIPANTS, EFFECTIVE AS OF JULY 1, 2005, OR SUCH OTHER DATE AGREED UPON BY THE PARTICIPANTS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED IN DETAIL BY THE ORGANIZATION'S MANAGEMENT. THEN A FINAL DRAFT OF THE FULL FORM 990, INCLUDING APPLICABLE SCHEDULES, IS MADE AVAILABLE TO THE FINANCE COMMITTEE AT A REGULARLY SCHEDULED MEETING WITH OUR TAX ADVISORS PRESENT. EACH REMAINING MEMBER OF THE BOARD OF GOVERNANCE IS ALSO PROVIDED A FINAL DRAFT OF THE FULL FORM 990 FOR REVIEW. THESE REVIEWS OCCUR PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C COVERED PERSONS: ALL MANAGEMENT PERSONNEL AND MEMBERS OF THE BOARD OF DIRECTORS ARE COVERED UNDER THE ORGANIZATION'S CONFLICT OF INTEREST POLICY. MANAGEMENT PERSONNEL INCLUDE SUPERVISORS THROUGH THE PRESIDENT/CEO OF THE ORGANIZATION. POLICY SUMMARY: THE CONFLICT-OF-INTEREST POLICY IS SENT OUT TO COVERED PERSONS FOR REVIEW. EACH PERSON IS REQUIRED TO COMPLETE THE CONFLICT OF INTEREST QUESTIONNAIRE AND RETURN IT. IT IS THE RESPONSIBILITY OF HUMAN RESOURCES AND THE EXECUTIVE ASSISTANT TO ENSURE THE QUESTIONNAIRES ARE RETURNED AND COMPLETED. THE COMPLETED QUESTIONNAIRES ARE FORWARDED TO THE VICE PRESIDENT OF HUMAN RESOURCES FOR REVIEW TO DETERMINE IF CONFLICTS EXIST. AN INTERESTED PERSON HAS A CONFLICT OF INTEREST WITH RESPECT TO A CONTRACT, TRANSACTION OR ARRANGEMENT IN WHICH ALVERNO PROVENA HOSPITAL LABORATORIES, INC. (APHL) IS (OR WOULD BE, IF APPROVED) A PARTY IF THE PERSON HAS, DIRECTLY OR INDIRECTLY, THROUGH A BUSINESS, INVESTMENT, FAMILY OR OTHER RELATIONSHIP: A) AN OWNERSHIP OR INVESTMENT INTEREST IN ANY ENTITY INVOLVED IN SUCH CONTRACT, TRANSACTION OR ARRANGEMENT; B) A COMPENSATION ARRANGEMENT WITH AN INDIVIDUAL OR ENTITY INVOLVED IN SUCH CONTRACT, TRANSACTION OR ARRANGEMENT; C) A POTENTIAL OWNERSHIP OR INVESTMENT INTEREST IN, OR COMPENSATION ARRANGEMENT WITH, AN INDIVIDUAL OR ENTITY WITH WHICH APHL IS NEGOTIATING SUCH CONTRACT, TRANSACTION OR ARRANGEMENT; OR D) A FIDUCIARY POSITION (E.G., MEMBER, OFFICER, DIRECTOR, COMMITTEE MEMBER) WITH RESPECT TO AN ENTITY IN SUCH CONTRACT, TRANSACTION OR ARRANGEMENT; OR E) A NON-ECONOMIC AFFILIATION OR RELATIONSHIP, DIRECTLY (OR INDIRECTLY, THROUGH A THIRD PARTY) WITH AN INDIVIDUAL OR ENTITY WITH WHICH APHL IS NEGOTIATING OR MAINTAINS A CONTRACT, TRANSACTION OR ARRANGEMENT SUCH THAT THE AFFILIATION OR RELATIONSHIP COULD RENDER THE INTERESTED PERSON INCAPABLE OF MAKING A DECISION WITH ONLY THE BEST INTERESTS OF APHL IN MIND. IN ADDITION, AN INTERESTED PERSON HAS A CONFLICT OF INTEREST IN ANY EXISTING OR POTENTIAL COMPENSATION ARRANGEMENT BETWEEN APHL AND THAT INTERESTED PERSON OR ANY BUSINESS, INVESTMENT OR FAMILY MEMBER RELATED TO THAT PERSON. FOR PURPOSES OF THIS SECTION, COMPENSATION INCLUDES DIRECT AND INDIRECT REMUNERATION, AS WELL AS GIFTS OR FAVORS THAT ARE SUBSTANTIAL IN NATURE. SERVICE OF INDIVIDUALS ON THE BOARD OF DIRECTORS FOR ALVERNO PROVENA HOSPITAL LABORATORIES, INC. (AND COMMITTEES THEREOF), BOARDS OR COMMITTEES OF THE MEMBER ORGANIZATIONS OR EMPLOYMENT BY A MEMBER ORGANIZATION OR ALVERNO CLINICAL LABORATORIES, A RELATED ORGANIZATION, IS NOT CONSIDERED A CONFLICT OF INTEREST, AS DEFINED IN THE POLICY. THE VP OF HUMAN RESOURCES COMPILES THE RESULTS AND FORWARDS THE RESULTS TO THE CEO. THE ASSESSMENTS OF ANY POTENTIAL CONFLICT ARE MADE IN COLLABORATION WITH LEGAL COUNSEL AS APPROPRIATE. THE CEO REVIEWS ANY CONFLICTS WITH THE BOARD DURING A SCHEDULED BOARD MEETING. POLICY VIOLATIONS: IF THE BOARD OR MANAGERS HAS REASON TO BELIEVE THAT AN INTERESTED PERSON HAS FAILED TO COMPLY WITH THE DISCLOSURE OBLIGATIONS OF THIS POLICY, THE BOARD OF MANAGERS SHALL INFORM THAT PERSON OF THE BASIS FOR ITS BELIEF AND PROVIDE THAT PERSON AN OPPORTUNITY TO ADDRESS THE ALLEGED FAILURE TO DISCLOSE. AFTER HEARING THE RESPONSE OF SUCH A PERSON AND CONDUCTING FURTHER INVESTIGATION AS MAY BE WARRANTED UNDER THE CIRCUMSTANCES, THE BOARD OF MANAGERS SHALL DETERMINE WHETHER SUCH PERSON HAS IN FACT, VIOLATED THE DISCLOSURE REQUIREMENTS OF THE CONFLICT-OF-INTEREST POLICY. IF THE BOARD DETERMINES THAT THERE HAS BEEN A VIOLATION, THE BOARD SHALL TAKE APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION, WHICH MAY INCLUDE REMOVAL (IF THE INTERESTED PERSON IS A BOARD OR COMMITTEE MEMBER, DIRECTOR, OR MANAGEMENT EMPLOYEE) OR TERMINATION (IF THE INTERESTED PERSON IS AN EMPLOYEE OF ALVERNO PROVENA HOSPITAL LABORATORIES, INC., ALVERNO CLINICAL LABORATORIES, LLC OR A MEMBER ORGANIZATION). RESTRICTIONS IMPOSED ON PERSONS WITH A CONFLICT ARE DETERMINED ON A CASE-BY-CASE BASIS BY THE CEO IN COLLABORATION WITH LEGAL COUNSEL. AS OF THIS DATE, NO MATERIAL CONFLICTS OF INTEREST HAVE BEEN IDENTIFIED. IF A MATERIAL CONFLICT IS IDENTIFIED IN THE FUTURE, THAT PERSON WOULD BE REQUIRED TO RECUSE THEMSELVES FROM PARTICIPATING IN DECISIONS AND/OR VOTING PRIVILEGES DIRECTLY RELATED TO THE CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 FORM 990 PART VI LINE 15A THE ORGANIZATION'S TOP MANAGEMENT OFFICIAL IS PAID BY ALVERNO CLINICAL LABORATORIES, LLC, A RELATED ORGANIZATION; THEREFORE, THIS QUESTION HAS BEEN ANSWERED NO IN ACCORDANCE WITH THE FORM 990 INSTRUCTIONS. THE BOARD OF DIRECTORS APPOINTED A COMPENSATION COMMITTEE, WHICH IS A SUB-COMMITTEE OF THE BOARD. THE COMPENSATION FOR THE PRESIDENT/CEO IS REVIEWED BY SYSTEM REPRESENTATIVES APPOINTED TO THE BOARD. SALARY INCREASES ARE APPROVED ANNUALLY. THE BUDGET IS RECOMMENDED FOR APPROVAL OR APPROVED ANNUALLY BY THE FINANCE COMMITTEE, BOARD MEMBERS FROM EACH PARTICIPATING SYSTEM AND SYSTEM REPRESENTATIVES APPOINTED TO THE BOARD BY THE SYSTEM CEO'S. FORM 990 PART VI LINE 15B THE ORGANIZATION'S OTHER OFFICERS AND KEY EMPLOYEES ARE PAID BY ALVERNO CLINICAL LABORATORIES, LLC, A RELATED ORGANIZATION; THEREFORE, THIS QUESTION HAS BEEN ANSWERED NO IN ACCORDANCE WITH THE FORM 990 INSTRUCTIONS. SEE NARRATIVE FOR FORM 990, PART VI, SECTION B, LINE 15A. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G PURCHASED SVC-OTHER: PROGRAM SERVICE EXPENSES 4,795,437. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 4,795,437. AL LAB SERVICES: PROGRAM SERVICE EXPENSES 47,665,401. MANAGEMENT AND GENERAL EXPENSES -1,250,340. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 46,415,061. ACL MANAGEMENT SERVICES: PROGRAM SERVICE EXPENSES 6,774,565. MANAGEMENT AND GENERAL EXPENSES 4,284,690. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 11,059,255. ALVERNO CLINICAL LAB LLC 2434 INTERSTATE PLAZA DR HAMMOND IN 46324 203240648 MANAGEMENT SVCS IN N/A 0 0 ALVERNO LAB LLC 2434 INTERSTATE PLAZA DR HAMMOND IN 46324 300711211 MEDICAL SERVICES IN N/A 0 0 0 0 0 1 1 0 0 0 0 0 0 1 1 0 1 0 0 0 0 SCHEDULE R, PART III LISTED BELOW ARE THE COMPLETE NAMES AND STREET ADDRESSES FOR PART III: 1) ALVERNO CLINICAL LABORATORIES, LLC; 2434 INTERSTATE PLAZA DRIVE; HAMMOND, IN 46324 2) ALVERNO LABORATORIES, LLC; 2434 INTERSTATE PLAZA DRIVE; HAMMOND, IN 46324